Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q2 2025 Earnings Call Transcript August 11, 2025
Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.83.
Operator: Good day, everyone. My name is Olivia, and I will be your conference operator today. At this time, I would like to welcome you to the Kymera Therapeutics Second Quarter 2025 Results Call. [Operator Instructions] At this time, I would like to turn the call over to Bruce Jacobs, Chief...
